PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Anti-HIV drug use during pregnancy does not affect infant size, birth weight

NIH study indicates drug safe during pregnancy, but infants smaller at first birthday

2012-05-02
(Press-News.org) Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study. However, at 1 year of age, children born to the tenofovir-treated mothers were slightly shorter and had slightly smaller head circumference—about 1 centimeter each, on average—than were infants whose mothers did not take tenofovir.

The study authors described the findings as reassuring, noting that the study did not identify any serious safety concerns during pregnancy for tenofovir. In combination with other anti-HIV drugs, tenofovir is the first line of treatment for adults with HIV. The researchers called for additional studies to follow the children as they grow and develop, to identify any potential long term effects of the treatment. Information on Tenofovir and formulations containing tenofovir is available at http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000198/.

The study was undertaken because earlier studies had shown laboratory animals exposed to tenofovir in the womb were smaller at birth than were their unexposed peers.

Because of its safety and effectiveness, many women who have HIV take the drug for their health, often before they become pregnant. Similarly, because the drug is so effective for adult use and because there have been no problems reported in human infants related to their mother's use of tenofovir, many physicians will prescribe it for pregnant women, both to safeguard the women's health and to prevent the virus from being passed on to their infants. However, before the current research, the drug had not been specifically studied for its potential effects on infants whose mothers took it during pregnancy.

"Physicians treating pregnant women for HIV face a dilemma: do they continue treating a pregnant woman with a drug that is highly effective for adults but which has not been studied for its effects on infants, or do they switch the woman to another therapy, which may not be as effective and well-tolerated?" said first author George K. Siberry, M.D., of the Pediatric, Adolescent and Maternal AIDS Branch of the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the NIH institute that conducted the study. "Our findings indicate that tenofovir does not affect the growth of the fetus."

Over the seven years of the study, the number of participants being treated with tenofovir increased sharply, the study authors noted. In 2003, 14 percent of mothers in the study had been prescribed the drug, compared with 43 percent in 2010.

"The priority has been to treat mothers and prevent an infant's infection," said co-author Paige L. Williams, Ph.D., of the Harvard School of Public Health, Boston. "However, it's important to monitor the effects of these drugs on the infant."

The research was conducted as part of the Pediatric HIV/AIDS Cohort Study (PHACS), which is supported by the NICHD, the National Institute of Allergy and Infectious Diseases, the National Institute on Drug Abuse, the National Institute of Mental Health, the National Institute on Deafness and other Communication Disorders, the National Heart, Lung, and Blood Institute, the National Institute of Neurological Disorders and Stroke, and the National Institute on Alcohol Abuse and Alcoholism.

Dr. Siberry and Dr. Williams collaborated with colleagues at the State University of New York Downstate, Brooklyn; University of Miami School of Medicine; Indiana University School of Medicine, Indianapolis; Harvard; and the NICHD.

Their findings appear online in the journal AIDS.

The study included 2,000 U.S. infants born to HIV-positive mothers between 2003 and 2010. The researchers collected data for the infants' size relative to their gestational age (time they had spent in the womb), their birth weight, length at birth, and the circumference of their head. The researchers recorded similar measurements when the child was 1 year old.

They found that mothers taking tenofovir in combination with other anti-HIV medications and mothers on anti-HIV drug combinations that did not include tenofovir gave birth to infants who were smaller, on average, than infants born to HIV-negative mothers. However, they did not find significant differences between infants from the two groups of HIV-positive mothers.

The tenofovir-exposed infant's smaller average size and head circumference at one year of age suggests tenofovir could have a delayed effect on growth. Further research on this and other classes of anti-HIV drugs is ongoing in the PHACS.

"Overall, this study produced reassuring information regarding the use of tenofovir," said Dr. Siberry. "Although further research is needed, on balance, our findings favor the use of tenofovir in pregnancy to ensure good outcomes in the mother and prevent transmission of HIV to the infant."

### About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): The NICHD sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. For more information, visit the Institute's website at http://www.nichd.nih.gov/.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.


ELSE PRESS RELEASES FROM THIS DATE:

Researchers gain better understanding of mechanism behind tau spreading in the brain

2012-05-02
Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function. Previous studies have shown that the abnormal folding, or misfolding, and buildup of tau are key neuropathological features ...

Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma

2012-05-02
Low dose whole body CT is nearly four times better than radiographic skeletal survey, the standard of care in the U.S., for determining the extent of disease in patients with multiple myeloma, a new study shows. The study, conducted at the University of Maryland in Baltimore, included 51 patients who had both a radiographic skeletal survey as well as a low dose whole body CT examination. The total number of lesions detected in these patients with low dose whole body CT was 968 versus 248 detected by radiographic skeletal survey, said Kelechi Princewill, MD, the lead author ...

Michaels Inspires Dads With Easy Ideas for Handmade Mother's Day Gifts

Michaels Inspires Dads With Easy Ideas for Handmade Mothers Day Gifts
2012-05-02
Dad may be better with a hammer than a glue gun, but Michaels makes it easy for dads to help their children create special Mother's Day gifts for Mom. With hundreds of DIY gift ideas online and low-cost in-store gift-making events from Michaels, dads and their children will have fun creating a memorable handmade gift. Dads with an artistic flair can help their children create personalized handmade cards, while dads and kids with green thumbs can embellish garden stepping stones. From decorated mugs to custom designed apparel to festive cupcakes, Michaels features quick ...

Cone beam CT proves better for visualizing some causes of hearing loss at half the radiation dose

2012-05-02
Cone beam CT is superior to mutidetector CT for detecting superior semicircular canal dehiscence or the so called third window (a small hole in the bony wall of the inner ear bone that can cause dizziness and hearing loss) and it uses half the radiation dose, a new study shows. The study, conducted in Bruges, Belgium, included 21 patients who had both a cone beam CT and a multidetector CT examination of their right and left temporal bones, said David Volders, MD, one of the authors of the study. Two radiologists reviewed the images from both exams and scored them based ...

Soft & Shield Hand Sanitizer and Moisturizer, a Safe and Healthy Alternative to Alcohol Based Hand Sanitizers

Soft & Shield Hand Sanitizer and Moisturizer, a Safe and Healthy Alternative to Alcohol Based Hand Sanitizers
2012-05-02
The current news and publicity of teenagers consuming alcohol based hand sanitizers in an effort to get intoxicated has alarmed parents. In addition, there have been recent reports of many cases of alcohol poisoning by children under 5 from ingesting alcohol hand sanitizers. We believe consumers are seeking a superior and safer product for their families to use. Many public health officials are becoming worried that these types of incidents could be evidence of a dangerous and serious new fad. With these alarming new reports, we believe concerned parents need a safer ...

JCI early table of contents for April 30, 2012

2012-05-01
ONCOLOGY Lymphoma therapy could deliver a double punch | Back to top B cell lymphomas are a group of cancers of that originate in lymphoid tissue from B cells, the specialized immune cell type that produces antibodies. The development of B cell lymphoma is associated with several known genetic changes, including increased expression of MYC, a transcription factor that promotes cell growth and division. In this issue of the JCI, Andrei Thomas-Tikhonenko and his colleagues at the University of Pennsylvania in Philadelphia report on their studies to better understand the ...

UC Davis researchers create molecule that blocks pathway leading to Alzheimer's disease

2012-05-01
UC Davis researchers have found novel compounds that disrupt the formation of amyloid, the clumps of protein in the brains of people with Alzheimer's disease believed to be important in causing the disease's characteristic mental decline. The so-called "spin-labeled fluorene compounds" are an important new target for researchers and physicians focused on diagnosing, treating and studying the disease. The study, published today in the online journal PLoS ONE, is entitled "The influence of spin-labeled fluorene compounds on the assembly and toxicity of the Aβ peptide." "We ...

Key lessons from history on alcohol taxes

2012-05-01
Steep rises in taxes on alcohol do not necessarily reduce consumption, according to research funded by the Economic and Social Research Council (ESRC) into the history of intoxicants in 16th and 17th England. Dr Philip Withington at the University of Cambridge has found that affluence rather than poverty has tended to drive consumption levels, especially among the middle classes and higher,even though legislation and enforcement is often focused on the poorer parts of the population. "If alcohol consumption is traditionally an index of affluence, then minimum pricing ...

Courtship in the cricket world

2012-05-01
Everyone wants to present themselves in the best light - especially when it comes to finding a partner. Some rely on supplying honest information about their attributes while others exaggerate for good effect. A new study by researchers at the University of Bristol, published in PNAS, has discovered how male crickets could use similar tactics to attract a mate. Male crickets advertise for mates by singing loud repetitive songs at night. They rub their wings together, setting them into resonant vibration, making a loud and intense sound, which enables the female crickets ...

Control of gene expression: Histone occupancy in your genome

Control of gene expression: Histone occupancy in your genome
2012-05-01
KANSAS CITY, MO—When stretched out, the genome of a single human cell can reach six feet. To package it all into a tiny nucleus, the DNA strand is tightly wrapped around a core of histone proteins in repeating units—each unit known as a nucleosome. To allow access for the gene expression machinery the nucleosomes must open up and regroup when the process is complete. In the May 1, 2012, issue of Genes & Development, researchers at the Stowers Institute for Medical Research demonstrate how failure to restore order has lasting consequences. During the process of gene ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Anti-HIV drug use during pregnancy does not affect infant size, birth weight
NIH study indicates drug safe during pregnancy, but infants smaller at first birthday